Format

Send to

Choose Destination
Sci Rep. 2016 Oct 20;6:35613. doi: 10.1038/srep35613.

Imaging hydrogen peroxide in Alzheimer's disease via cascade signal amplification.

Author information

1
Molecular Imaging Laboratory, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 01890, USA.
2
School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
3
College of Pharmaceutical Sciences, Soochow University, Suzhou, 215006, China.
4
Division of Nuclear Medicine and Molecular Imaging &Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital and Department of Radiology, Harvard Medical School, Boston, MA, 02114, USA.

Abstract

In brains of Alzheimer's disease (AD), reactive oxygen species (ROS) levels are significantly higher than that of healthy brains. Evidence suggests that, during AD onset and progression, a vicious cycle revolves around amyloid beta (Aβ) production, aggregation, plaque formation, microglia/immunological responses, inflammation, and ROS production. In this cycle, ROS species play a central role, and H2O2 is one of the most important ROS species. In this report, we have designed a fluorescent imaging probe CRANAD-88, which is capable of cascade amplifying near infrared fluorescence (NIRF) signals at three levels upon interacting with H2O2 in AD brains. We demonstrated that the amplification was feasible in vitro and in vivo. Remarkably, we showed that, for the first time, it was feasible to monitor the changes of H2O2 concentrations in AD brains before and after treatment with an H2O2 scavenger. Our method opens new revenues to investigate H2O2 in AD brains and can be very instructive for drug development.

PMID:
27762326
PMCID:
PMC5071891
DOI:
10.1038/srep35613
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center